328 related articles for article (PubMed ID: 25597706)
1. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels.
Ase AR; Honson NS; Zaghdane H; Pfeifer TA; Séguéla P
Mol Pharmacol; 2015 Apr; 87(4):606-16. PubMed ID: 25597706
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine derivatives with P2X4 receptor-blocking activity.
Tian M; Abdelrahman A; Weinhausen S; Hinz S; Weyer S; Dosa S; El-Tayeb A; Müller CE
Bioorg Med Chem; 2014 Feb; 22(3):1077-88. PubMed ID: 24411477
[TBL] [Abstract][Full Text] [Related]
3. P2X4 subunits are part of P2X native channels in murine myenteric neurons.
Nieto-Pescador MG; Guerrero-Alba R; Valdez-Morales E; Espinosa-Luna R; Jiménez-Vargas N; Liñan-Rico Andrómeda A; Ramos-Lomas TL; Díaz-Hernández Verónica V; Montaño LM; Barajas-López C
Eur J Pharmacol; 2013 Jun; 709(1-3):93-102. PubMed ID: 23567069
[TBL] [Abstract][Full Text] [Related]
4. An Allosteric Inhibitory Site Conserved in the Ectodomain of P2X Receptor Channels.
Ase AR; Therrien É; Séguéla P
Front Cell Neurosci; 2019; 13():121. PubMed ID: 31024257
[TBL] [Abstract][Full Text] [Related]
5. P2X4 Receptor-Dependent Ca
Layhadi JA; Fountain SJ
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077063
[TBL] [Abstract][Full Text] [Related]
6. Identification of the molecular determinants of antagonist potency in the allosteric binding pocket of human P2X4.
Pasqualetto G; Zuanon M; Brancale A; Young MT
Front Pharmacol; 2023; 14():1101023. PubMed ID: 36843952
[TBL] [Abstract][Full Text] [Related]
7. ATP Evokes Ca
Layhadi JA; Turner J; Crossman D; Fountain SJ
J Immunol; 2018 Feb; 200(3):1159-1168. PubMed ID: 29255078
[TBL] [Abstract][Full Text] [Related]
8. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the inhibitory effects of the benzodiazepine derivative, 5-BDBD on P2X4 purinergic receptors by two complementary methods.
Balázs B; Dankó T; Kovács G; Köles L; Hediger MA; Zsembery A
Cell Physiol Biochem; 2013; 32(1):11-24. PubMed ID: 23867750
[TBL] [Abstract][Full Text] [Related]
10. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
[TBL] [Abstract][Full Text] [Related]
11. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
Caseley EA; Muench SP; Fishwick CW; Jiang LH
Biochem Pharmacol; 2016 Sep; 116():130-9. PubMed ID: 27481062
[TBL] [Abstract][Full Text] [Related]
12. Extracellular binding sites of positive and negative allosteric P2X4 receptor modulators.
Weinhausen S; Nagel J; Namasivayam V; Spanier C; Abdelrahman A; Hanck T; Hausmann R; Müller CE
Life Sci; 2022 Dec; 311(Pt A):121143. PubMed ID: 36328074
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into the allosteric inhibition of P2X4 receptors.
Shen C; Zhang Y; Cui W; Zhao Y; Sheng D; Teng X; Shao M; Ichikawa M; Wang J; Hattori M
Nat Commun; 2023 Oct; 14(1):6437. PubMed ID: 37833294
[TBL] [Abstract][Full Text] [Related]
14. Lithocholic acid inhibits P2X2 and potentiates P2X4 receptor channel gating.
Sivcev S; Slavikova B; Ivetic M; Knezu M; Kudova E; Zemkova H
J Steroid Biochem Mol Biol; 2020 Sep; 202():105725. PubMed ID: 32652201
[TBL] [Abstract][Full Text] [Related]
15. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
[TBL] [Abstract][Full Text] [Related]
16. Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors.
Bidula S; Nadzirin IB; Cominetti M; Hickey H; Cullum SA; Searcey M; Schmid R; Fountain SJ
Mol Pharmacol; 2022 Jan; 101(1):33-44. PubMed ID: 34718224
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone II A sulfonate, but not tanshinone II A, acts as potent negative allosteric modulator of the human purinergic receptor P2X7.
Kaiser M; Sobottka H; Fischer W; Schaefer M; Nörenberg W
J Pharmacol Exp Ther; 2014 Sep; 350(3):531-42. PubMed ID: 24970925
[TBL] [Abstract][Full Text] [Related]
18. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.
Bowler JW; Bailey RJ; North RA; Surprenant A
Br J Pharmacol; 2003 Oct; 140(3):567-75. PubMed ID: 12970084
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of P2X4 function by P2Y6 UDP receptors in microglia.
Bernier LP; Ase AR; Boué-Grabot É; Séguéla P
Glia; 2013 Dec; 61(12):2038-49. PubMed ID: 24123515
[TBL] [Abstract][Full Text] [Related]
20. Purinergic P2X receptors: structural models and analysis of ligand-target interaction.
Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R
Eur J Med Chem; 2015 Jan; 89():561-80. PubMed ID: 25462266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
